Literature DB >> 6208682

Characterization of H2 influenza virus hemagglutinin with monoclonal antibodies: influence of receptor specificity.

A Yamada, L E Brown, R G Webster.   

Abstract

Antigenic analysis of human and avian H2 influenza viruses were done with monoclonal antibodies to the HA molecules in hemagglutination inhibition (HI) assays. These studies revealed that the receptor-binding specificity of the hemagglutinin can markedly influence the antigenic analysis obtained with monoclonal antibodies in HI tests. Influenza viruses that are sensitive or resistant to inhibition by horse serum inhibitors showed marked differences in their reactivity with monoclonal antibodies to the hemagglutinin. This was apparent with the A/RI/5+/57 and A/RI/5-/57 strains of H2N2 viruses isolated by Choppin and Tamm (1960a), half of the panel of different monoclonal antibodies failed to inhibit hemagglutination of the RI/5- variant, whereas all of the 18 monoclonal antibodies inhibited RI/5+. These findings have important implications in the antigenic analysis of influenza viruses where HI assays are conventionally used to determine the extent of antigenic drift in nature. Antigenic differences were detectable between different human H2 influenza virus isolates from 1957 that were sensitive to inhibition by horse serum, indicating that minor antigenic variation occurs within the first year of appearance of the new subtype. Minor antigenic variation continued in the H2 viruses until 1961, but by 1962 antigenically distinguishable variants that could be discriminated with both monoclonal antibodies and postinfection ferret antisera predominated. Analysis of avian H2 influenza viruses with a panel of monoclonal antibodies indicated that antigenic variation occurs and that multiple different variants cocirculate in the population. There was no progressive antigenic change in the avian H2 influenza viruses with time, as was found with the human H2N2 strains. Topographical mapping of the H2 hemagglutinin by selection of antigenic variants with monoclonal antibodies and analysis of their reactivity patterns by HI showed overlap between the epitopes examined. These results may reflect restriction in the antibody repertoire of the mice used in preparation of the monoclonal antibodies or that the H2 hemagglutinin does not have such discrete nonoverlapping antigenic regions found in the early H3 influenza virus.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6208682     DOI: 10.1016/0042-6822(84)90351-9

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  An analysis of the properties of monoclonal antibodies directed to epitopes on influenza virus hemagglutinin.

Authors:  L E Brown; J M Murray; D O White; D C Jackson
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

Review 2.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

3.  The translocation, folding, assembly and redox-dependent degradation of secretory and membrane proteins in semi-permeabilized mammalian cells.

Authors:  R Wilson; A J Allen; J Oliver; J L Brookman; S High; N J Bulleid
Journal:  Biochem J       Date:  1995-05-01       Impact factor: 3.857

4.  Synthetic sialylphosphatidylethanolamine derivatives bind to human influenza A viruses and inhibit viral infection.

Authors:  C T Guo; C H Wong; T Kajimoto; T Miura; Y Ida; L R Juneja; M J Kim; H Masuda; T Suzuki; Y Suzuki
Journal:  Glycoconj J       Date:  1998-11       Impact factor: 2.916

5.  Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses.

Authors:  Jens C Krause; Tshidi Tsibane; Terrence M Tumpey; Chelsey J Huffman; Randy Albrecht; David L Blum; Irene Ramos; Ana Fernandez-Sesma; Kathryn M Edwards; Adolfo García-Sastre; Christopher F Basler; James E Crowe
Journal:  J Virol       Date:  2012-03-28       Impact factor: 5.103

6.  B cell responses to H5 influenza HA in human subjects vaccinated with a drifted variant.

Authors:  Jane Baer; Felix Santiago; Hongmei Yang; Hulin Wu; Jeanne Holden-Wiltse; John Treanor; David J Topham
Journal:  Vaccine       Date:  2009-11-21       Impact factor: 3.641

7.  In vitro responses to avian influenza H5 by human CD4 T cells.

Authors:  Matthew F Cusick; Shuping Wang; David D Eckels
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422

Review 8.  Evolution of cell recognition by viruses: a source of biological novelty with medical implications.

Authors:  Eric Baranowski; Carmen M Ruiz-Jarabo; Nonia Pariente; Nuria Verdaguer; Esteban Domingo
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

9.  Host versus flu: antibodies win a round?

Authors:  Christopher B Brooke; Jonathan W Yewdell
Journal:  Nat Struct Mol Biol       Date:  2013-03       Impact factor: 15.369

10.  Studies on the genetic determinants of influenza virus pathogenicity for mice with the use of reassortants between mouse-adapted and non-adapted variants of the same virus strain.

Authors:  I A Rudneva; N V Kaverin; N L Varich; A K Gitelman; A M Makhov; S M Klimenko; V M Zhdanov
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.